Sanofi: Encephalitis, Japanese trials

The registry lists 18 Encephalitis, Japanese studies with Sanofi as lead sponsor. 0 are open to participants now and 17 have results posted.

Phase 2 6Phase 3 10Phase 4 1No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy SubjectsCompletedNCT02492165Phase 3Results posted
• Post-licensure Safety Study of IMOJEV® in ThailandCompletedNCT01981967Phase 4Results posted
• Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South KoreaCompletedNCT01900444Phase 3Results posted
• Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in ToddlersCompletedNCT01396512Phase 3Results posted
• Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CVCompletedNCT01190228Phase 3Results posted
• Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese ToddlersCompletedNCT01188343Phase 3Results posted
• A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and ToddlersCompletedNCT01092507Phase 3Results posted
• Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in ToddlersCompletedNCT01001988Phase 3Results posted
• Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)CompletedNCT00982137Phase 2Results posted
• Study of Live Attenuated ChimeriVax™-Japanese Encephalitis VaccineCompletedNCT00981630Phase 2Results posted
• A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy AdultsCompletedNCT00981175Phase 2Results posted
• Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the PhilippinesCompletedNCT00735644Phase 3Results posted
• Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and ChildrenCompletedNCT00621764Phase 2Results posted
• Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending AgeCompletedNCT00441259Phase 2Results posted
• A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAXCompletedNCT00319592Phase 2Results posted
• A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAXCompletedNCT00314145Phase 3Results posted
• Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.CompletedNCT00314132Phase 3Results posted
• Postmarketing Surveillance Study for IMOJEV® in Republic of KoreaCompletedNCT02933710